Market Cap 1.94B
Revenue (ttm) 150,000.00
Net Income (ttm) -59.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,566.66%
Debt to Equity Ratio 0.00
Volume 14,600
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 105.00M
Stochastic %K N/A
Beta N/A
Analysts Sell
Price Target $19.12

Company Profile

Under normal circumstances, the fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity securities of Trillion Companies and/or financial instruments (such as swaps) that provide indirect exposure to Trillion Companies. The index tracks the performance of U.S. exchange-listed companies with market capitalizations of $1 trillion or greater (“Trillion Companies”). The fund is non-diversified.

MitosisMoney
MitosisMoney Dec. 25 at 12:11 PM
$TRIL The opportunity set remains meaningful, but only if discipline keeps pace with ambition. The market is increasingly intolerant of delays that stretch credibility. Without proof, upside scenarios remain hypothetical and heavily discounted. The market will respond to evidence, not speculation.
0 · Reply
thenewmoney
thenewmoney Oct. 1 at 4:01 PM
There’s a select group of public companies who have exceeded a market capitalization of a trillion dollars or more. And now, they have their very own ETF. $TRIL https://share.thenew.money/article/theres-a-new-etf-on-wall-street-for-trillion-dollar-companies-and-assets
0 · Reply
ValueHawk23
ValueHawk23 Sep. 17 at 12:50 PM
0 · Reply
Smittysixty
Smittysixty Sep. 2 at 7:38 PM
$PPBT The Biotech Playbook in Motion Volume spikes. Price suppression. Troll surge. Seen it before: $IMMU, $ARNA, $TRIL. Same setup. Same silence. Same endgame. Retail’s not rattled. Shorts are.
0 · Reply
WAYWARD_SUN
WAYWARD_SUN Aug. 14 at 7:00 PM
0 · Reply
volality
volality May. 24 at 7:39 PM
$IMNN Historical data from a drug stock $TRIL a few years back. They did a private placement before the BO This could be similar. JMO
1 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 10:33 PM
2 · Reply
Whtmtn
Whtmtn May. 8 at 2:01 PM
$ADAPY Some interesting tidbits from the 10K that I just got around to reading: The risk factors are longer than a Charlie Manson rap sheet, there are now 266M shares outstanding (I believe from ~8M options granted in Q1'25 with 4M at the market strike and 4M at nominal or .01 strike), ~3.1M ADR equivalent options were forfeited or expired with avg exercise price of $3.00, 1.5M ADRs were exercised with avg exercise price of $0.05 and the 33% reduction in headcount Adrian advertised turned out to be 29%. There are 42M outstanding options with an avg ex price of $1.86, which means it's likely many will expire. The company received $77K for the exercised options in 2024, thank you employees such a sacrifice!! Sort of frames up where valuations might fall. This ain't no $TRIL.
0 · Reply
financialsarthis
financialsarthis Apr. 24 at 11:10 AM
Transformers, Power Giants & FIIs: Q4 Ownership Trends That May Surprise You! 🧵 Who’s Buying? Who’s Booking? 📊 Tracking FII, DII & Public shareholding shifts (Q4 vs Q3) in Power & Transformers👇 A Mega Thread🧵 $TRIL – Transformers & Rectifiers (India) Ltd 📈 FII: 11.08% → 11.33% 📉 DII: 7.68% → 7.22% 📈 Public: 16.88% → 17.07% $SIEMENS – Siemens Ltd 📉 FII: 8.77% → 8.19% 📈 DII: 6.78% → 7.29% 📈 Public: 9.45% → 9.51% $INDOTECH – Indo Tech Transformers 📉 FII: 0.48% → 0.24% ➖ DII: 0.66% → 0.66% 📈 Public: 23.85% → 24.08% $VOLTAMP – Voltamp Transformers 📉 FII: 26.70% → 23.91% 📉 DII: 23.70% → 23.53% 🚀 Public: 11.51% → 14.48% $CGPOWER – CG Power & Industrial Solutions 📉 FII: 14.30% → 12.97% 📈 DII: 11.91% → 13.58% 📉 Public: 15.73% → 15.39% $APARINDS – Apar Industries 📉 FII: 10.22% → 9.87% 📉 DII: 21.24% → 20.63% 📈 Public: 10.77% → 11.73% $BHARATBIJLEE – Bharat Bijlee 📉 FII: 5.30% → 3.79% 📉 DII: 17.77% → 17.34% 📈 Public: 43.26% → 45.19% $BHEL – Bharat Heavy Electricals Ltd 📉 FII: 7.98% → 7.19% 📈 DII: 15.49% → 16.34% 📉 Public: 13.36% → 13.29% $SHILCHAR – Shilchar Technologies 📉 FII: 2.29% → 2.05% ➖ DII: 0.11% → 0.11% 📈 Public: 33.06% → 33.30%
0 · Reply
EddieH2020
EddieH2020 Apr. 23 at 6:18 PM
$SLS Look up $TRIL buyout history next 👍
0 · Reply
Latest News on TRIL
ETF Prime: Murphy on the New Faces of the ETF Boom

Oct 29, 2025, 12:45 PM EDT - 2 months ago

ETF Prime: Murphy on the New Faces of the ETF Boom

DIME MEME PBOT PCLN PQNT


MitosisMoney
MitosisMoney Dec. 25 at 12:11 PM
$TRIL The opportunity set remains meaningful, but only if discipline keeps pace with ambition. The market is increasingly intolerant of delays that stretch credibility. Without proof, upside scenarios remain hypothetical and heavily discounted. The market will respond to evidence, not speculation.
0 · Reply
thenewmoney
thenewmoney Oct. 1 at 4:01 PM
There’s a select group of public companies who have exceeded a market capitalization of a trillion dollars or more. And now, they have their very own ETF. $TRIL https://share.thenew.money/article/theres-a-new-etf-on-wall-street-for-trillion-dollar-companies-and-assets
0 · Reply
ValueHawk23
ValueHawk23 Sep. 17 at 12:50 PM
0 · Reply
Smittysixty
Smittysixty Sep. 2 at 7:38 PM
$PPBT The Biotech Playbook in Motion Volume spikes. Price suppression. Troll surge. Seen it before: $IMMU, $ARNA, $TRIL. Same setup. Same silence. Same endgame. Retail’s not rattled. Shorts are.
0 · Reply
WAYWARD_SUN
WAYWARD_SUN Aug. 14 at 7:00 PM
0 · Reply
volality
volality May. 24 at 7:39 PM
$IMNN Historical data from a drug stock $TRIL a few years back. They did a private placement before the BO This could be similar. JMO
1 · Reply
WAYWARD_SUN
WAYWARD_SUN May. 23 at 10:33 PM
2 · Reply
Whtmtn
Whtmtn May. 8 at 2:01 PM
$ADAPY Some interesting tidbits from the 10K that I just got around to reading: The risk factors are longer than a Charlie Manson rap sheet, there are now 266M shares outstanding (I believe from ~8M options granted in Q1'25 with 4M at the market strike and 4M at nominal or .01 strike), ~3.1M ADR equivalent options were forfeited or expired with avg exercise price of $3.00, 1.5M ADRs were exercised with avg exercise price of $0.05 and the 33% reduction in headcount Adrian advertised turned out to be 29%. There are 42M outstanding options with an avg ex price of $1.86, which means it's likely many will expire. The company received $77K for the exercised options in 2024, thank you employees such a sacrifice!! Sort of frames up where valuations might fall. This ain't no $TRIL.
0 · Reply
financialsarthis
financialsarthis Apr. 24 at 11:10 AM
Transformers, Power Giants & FIIs: Q4 Ownership Trends That May Surprise You! 🧵 Who’s Buying? Who’s Booking? 📊 Tracking FII, DII & Public shareholding shifts (Q4 vs Q3) in Power & Transformers👇 A Mega Thread🧵 $TRIL – Transformers & Rectifiers (India) Ltd 📈 FII: 11.08% → 11.33% 📉 DII: 7.68% → 7.22% 📈 Public: 16.88% → 17.07% $SIEMENS – Siemens Ltd 📉 FII: 8.77% → 8.19% 📈 DII: 6.78% → 7.29% 📈 Public: 9.45% → 9.51% $INDOTECH – Indo Tech Transformers 📉 FII: 0.48% → 0.24% ➖ DII: 0.66% → 0.66% 📈 Public: 23.85% → 24.08% $VOLTAMP – Voltamp Transformers 📉 FII: 26.70% → 23.91% 📉 DII: 23.70% → 23.53% 🚀 Public: 11.51% → 14.48% $CGPOWER – CG Power & Industrial Solutions 📉 FII: 14.30% → 12.97% 📈 DII: 11.91% → 13.58% 📉 Public: 15.73% → 15.39% $APARINDS – Apar Industries 📉 FII: 10.22% → 9.87% 📉 DII: 21.24% → 20.63% 📈 Public: 10.77% → 11.73% $BHARATBIJLEE – Bharat Bijlee 📉 FII: 5.30% → 3.79% 📉 DII: 17.77% → 17.34% 📈 Public: 43.26% → 45.19% $BHEL – Bharat Heavy Electricals Ltd 📉 FII: 7.98% → 7.19% 📈 DII: 15.49% → 16.34% 📉 Public: 13.36% → 13.29% $SHILCHAR – Shilchar Technologies 📉 FII: 2.29% → 2.05% ➖ DII: 0.11% → 0.11% 📈 Public: 33.06% → 33.30%
0 · Reply
EddieH2020
EddieH2020 Apr. 23 at 6:18 PM
$SLS Look up $TRIL buyout history next 👍
0 · Reply
pkbull
pkbull Mar. 12 at 5:35 PM
@Soll2019 hey man, where have you been? It’s been a while since you have posted anything . I hope you’re doing well. I remember you from $TRIL
0 · Reply
BiotechValues
BiotechValues Jan. 30 at 2:50 PM
$BCAB contrarian play, but I think this can recover big in 2025. I've been buying back heavily in the $0.40s ($27M market cap). Reminds me of $TRIL years back before the huge run up. New slide deck says partnering in progress on ROR2 and CTLA4. $9M raise in Dec was likely bridge
2 · Reply
mikeyv6969
mikeyv6969 Jan. 24 at 1:09 AM
$ABUS One day we will look back and this will be a $TRIL type of move. Yes it’s taking ages, yes it’s annoying, but we have many good things coming. Be patient; if you truly believe buy more. Our day will come
1 · Reply
Vavavoom
Vavavoom Jan. 17 at 2:16 PM
$CRDF onva is a new class just as $TRIL ‘s molecules were . $ tril’s molecules already had competition from gilead’s takeover of a co with similar class of drugs . Onva for rx of a solid tumor which can happen in younger ppl - a better regimen should give them a fighting chance . $TRIL dropped from around $12 ( after good news in April 21 ) to almost $5 in sept before acquisition at $18.5 So who said MMs don’t play games ?
1 · Reply
TwitWalt
TwitWalt Jan. 2 at 5:58 PM
$QNCCF This could be signs of a merger. They beat the stock up to buy more ahead of the official meger. This happened to $TRIL before it was bought out by Pfizer. I never sold thru constant halts from like $1.00 to 23.00 before it was bought out.. Never any reason for the halts either. But who knows. I sure don't
0 · Reply
Xmarketsthestock
Xmarketsthestock Nov. 15 at 6:50 AM
0 · Reply
BloodyPortfolio
BloodyPortfolio Aug. 19 at 7:32 PM
$VKTX No Fade for the shorts! It's happening here - $TRIL $IMGN.
0 · Reply